We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.2B
AUM Growth
-$23.5M
Cap. Flow
-$2.12M
Cap. Flow %
-0.18%
Top 10 Hldgs %
19.22%
Holding
434
New
15
Increased
131
Reduced
227
Closed
25

Top Sells

Rank Stock Value
1
QVCGA
QVC Group Inc Series A
QVCGA
+$3.78M
2
CSCO icon
Cisco
CSCO
+$3.19M
3
C icon
Citigroup
C
+$2.55M
4
ED icon
Consolidated Edison
ED
+$1.68M
5
ETR icon
Entergy
ETR
+$1.6M

Sector Composition

Rank Sector Weight
1 Technology 19.14%
2 Financials 16.48%
3 Healthcare 13.7%
4 Industrials 9.22%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.71T
$35.6M 2.98%
849,808
-16,892
-2% -$727K
AMJ
2
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$34.9M 2.91%
1,453,548
+82,677
+6% +$2.27M
INTC icon
3
Intel
INTC
$502B
$26.5M 2.22%
509,340
-14,012
-3% -$666K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.06T
$25.6M 2.14%
128,380
+1,659
+1% +$341K
JNJ icon
5
Johnson & Johnson
JNJ
$624B
$23.1M 1.93%
179,885
+14,942
+9% +$2.02M
CMCSA icon
6
Comcast
CMCSA
$79.4B
$18.7M 1.56%
546,478
+6,437
+1% +$250K
NOC icon
7
Northrop Grumman
NOC
$75B
$17.7M 1.48%
50,763
-2,921
-5% -$978K
MSFT icon
8
Microsoft
MSFT
$2.83T
$16.8M 1.4%
183,645
-2,943
-2% -$269K
ELV icon
9
Elevance Health
ELV
$82.4B
$16.1M 1.34%
73,149
+1,416
+2% +$333K
PFE icon
10
Pfizer
PFE
$142B
$15.2M 1.27%
451,199
+14,428
+3% +$496K
EXC icon
11
Exelon
EXC
$48.4B
$15.2M 1.27%
545,657
+85,582
+19% +$2.31M
AET
12
DELISTED
Aetna Inc
AET
$15M 1.26%
88,978
+2,077
+2% +$373K
BAC icon
13
Bank of America
BAC
$431B
$14.8M 1.23%
492,446
-15,091
-3% -$474K
IEMG icon
14
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
$14.6M 1.22%
249,735
-14,761
-6% -$873K
UNH icon
15
UnitedHealth
UNH
$386B
$14.5M 1.21%
67,553
-1,954
-3% -$446K
ED icon
16
Consolidated Edison
ED
$41.5B
$14.1M 1.17%
180,272
-21,573
-11% -$1.68M
MU icon
17
Micron Technology
MU
$1.11T
$13.5M 1.13%
259,433
+4,227
+2% +$202K
IWC icon
18
iShares Micro-Cap ETF
IWC
$1.44B
$13M 1.08%
134,891
-1,593
-1% -$155K
AMGN icon
19
Amgen
AMGN
$199B
$12.9M 1.08%
75,816
-1,181
-2% -$217K
FNDX icon
20
Schwab Fundamental US Large Company Index ETF
FNDX
$26.3B
$12.8M 1.07%
1,054,533
+90,009
+9% +$1.13M
ALL icon
21
Allstate
ALL
$65.5B
$12.3M 1.02%
129,244
+2,807
+2% +$272K
TRV icon
22
Travelers Companies
TRV
$78.5B
$12M 1%
86,325
-560
-0.6% -$78.2K
TMO icon
23
Thermo Fisher Scientific
TMO
$214B
$11.8M 0.99%
57,288
-1,140
-2% -$239K
CA
24
DELISTED
CA, Inc.
CA
$11.8M 0.98%
347,596
+1,084
+0.3% +$37.7K
DIS icon
25
Walt Disney
DIS
$161B
$11.4M 0.95%
113,073
-957
-0.8% -$102K

Similar funds

RegentAtlantic Capital's Q1 2018 Portfolio in Review

As of Q1 2018, RegentAtlantic Capital held 434 positions worth $1.2B, down 1.9% from $1.22B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

RegentAtlantic Capital's Q1 2018 filing shows 15 new, 131 increased, 227 reduced and 25 closed positions. Its largest new stake was Charter Communications: 4,159 shares worth $1.29M. The largest sale was QVC Group Inc Series A, an estimated $3.78M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RegentAtlantic Capital's largest Q1 2018 buy was Charter Communications: 4,159 shares worth $1.29M.
  • RegentAtlantic Capital added most to DXC Technology in Q1 2018, an estimated $4.33M increase.
  • RegentAtlantic Capital's biggest Q1 2018 reduction was Cisco, cutting an estimated $3.19M.
  • RegentAtlantic Capital fully exited QVC Group Inc Series A in Q1 2018, selling an estimated $3.78M.
  • RegentAtlantic Capital's ten largest holdings make up 19% of its $1.2B portfolio in Q1 2018.
  • RegentAtlantic Capital opened 15 new positions and closed 25 in Q1 2018.
  • RegentAtlantic Capital's portfolio value fell 1.9% quarter-over-quarter to $1.2B.

Based on RegentAtlantic Capital's 13F filing for Q1 2018, filed 23 Apr 2018.